Reena is the Co-Leader of the firm's False Claims Act & Whistleblower Representation, Food & Beverage, and Financial Institution Subpoena Compliance Practices. She specializes in helping clients – in a variety of industries – comply with complicated legal regimes to avoid unwanted and unwarranted government scrutiny. Reena has a background in white collar criminal defense and has extensive experience representing clients in connection with civil and criminal government investigations and prosecutions, most notably in relation to:
- The Federal False Claims Act
- The Food, Drug, and Cosmetic Act
- The Foreign Corrupt Practices Act
- Tax fraud
- Environmental violations
- Contract disputes and civil fraud claims
Reena’s experience encompasses representing clients in the financial services, healthcare, manufacturing, pharmaceutical, construction, education, and real estate industries. Given the breadth of her experience, Reena has unique insight into the different patterns of investigations and opportunities for resolution.
Moreover, her background in litigating against, and also working with, the government gives her valuable insight in counseling clients on compliance and corporate governance matters and maintaining cooperative and helpful relationships with government regulators. Reena has also assisted companies in conducting internal investigations and in responding to, and addressing, government-initiated investigations, including responding to grand jury subpoenas, civil investigative demands, and other forms of legal process. She has also helped individuals navigate the complicated subpoena process when they unwittingly find themselves involved in a legal dispute.
Reena has extensive trial and appellate court experience, ensuring that clients have a strong and effective advocate when litigation becomes necessary. She has authored and presented on various topics relating to the False Claims Act, the Foreign Corrupt Practices Act, and New York State's food recycling law.
Services
Education
Dartmouth College, A.B.
George Washington University Law School, J.D., with highest honors
Admissions
- New York
Representative Work
Recognitions
- Western District of New York 2022 Pro Bono Award
- Named to Buffalo Business First Class of 2022 "40 Under 40," 2022
- Listed, Best Lawyers in America (Criminal Defense: White Collar) 2022 - 2025
- Pro Bono Honor Roll, The United States District Court for the Western District of New York, 2022
- Listed, Upstate New York Super Lawyers (Criminal Defense: White Collar) 2020 - 2024
- Leadership Buffalo, Class of 2020
- Listed, Upstate New York Super Lawyers Rising Stars, 2014 - 2019
- Finalist, Athena Young Professional Leadership Award, 2018
- Elected to the Board of Directors for the Bar Association of Erie County, 2018
- American Institute of Criminal Lawyers Ten Best Under 40, 2016
- Lawyers of Color Hot List, 2013
- Order of the Coif, George Washington University Law School
- Former associate, George Washington Law Review
News & Insights
- Press ReleaseHodgson Russ Press Release
- Press ReleaseHodgson Russ Press Release
- AlertHodgson Russ Healthcare Alert
- AlertHodgson Russ Home Care Alert
- AlertHodgson Russ Wine, Beer & Spirits Practice
- AlertHodgson Russ Healthcare Alert
- Press Release
- Press Release
- AlertHodgson Russ Home Care and Healthcare Alert
- AlertHodgson Russ Food & Beverage Alert
- Speaking EngagementJoseph A. Floreano Rochester Riverside Convention Center in Rochester, New York
- AlertHodgson Russ Food & Beverage Alert
- AlertHodgson Russ Food & Beverage Alert
- AlertHodgson Russ Home Care Alert
- Press Release
- SeminarHodgson Russ, 140 Pearl Street, Buffalo, NY 14202
- NewsBuffalo Business First
- AlertHodgson Russ Food and Beverage Alert
- Press ReleaseHodgson Russ Press Release
- Press ReleaseHodgson Russ Press Release
- AlertHodgson Russ Home Care Alert
- AlertHodgson Russ Canada-U.S. Cross-Border and Cybersecurity & Privacy Alert
- AlertHodgson Russ Home Care Alert
- NewsHodgson Russ OSHA and Healthcare Alert
- NewsBuffalo Business First
- NewsTax Stringer
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare and Labor & Employment Alert
- NewsHodgson Russ Healthcare and Labor & Employment Alert
- NewsHodgson Russ Healthcare and Labor & Employment Alert
- NewsCoronavirus Guidance Update - Healthcare
- NewsHodgson Russ Healthcare Alert
- Press ReleaseHodgson Russ Press Release
- Press ReleaseHodgson Russ Press Release
- NewsBuffalo Business First
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Food and Beverage Alert
- NewsHodgson Russ Food and Beverage Alert
- NewsHodgson Russ Food and Beverage Alert
- Webinar
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Cybersecurity and Privacy Alert
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsNational Association of Surety Bond Producers
- NewsCOVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- WebinarNovember 17, December 1 & 15, January 5 & 19
- NewsHodgson Russ Corporate & Business Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- Webinar
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- Webinar
- Press ReleaseHodgson Russ Press Release
- Webinar
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- Webinar
- NewsHodgson Russ Healthcare and Cybersecurity & Privacy Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- Webinar
- NewsHodgson Russ Cybersecurity & Privacy Alert
- Webinar
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- Webinar
- NewsHodgson Russ COVID-19 Litigation and Employment Action Team Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Business Litigation Alert
- NewsHodgson Russ Business Litigation and Bankruptcy & Restructuring Alert
- NewsHodgson Russ COVID-19 Litigation & Employment Action Team Alert
- NewsHodgson Russ Business Litigation Alert
- NewsHodgson Russ OSHA and Business Litigation Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Business Litigation Alert
- NewsHodgson Russ Business Litigation and Securities Regulation & Corporate Compliance Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Business Litigation Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Home Care Alert
- NewsHodgson Russ Business Litigation Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Food & Beverage Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Home Care Alert
- NewsHodgson Russ Food & Beverage Practice Alert
- NewsHodgson Russ Healthcare & OSHA Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Healthcare Alert
- NewsHodgson Russ Cybersecurity & Privacy Alert
- NewsHodgson Russ Healthcare Alert
- SeminarHodgson Russ LLP
- Blog Post
Fiscal Year 2019 was another banner year for False Claims Act recoveries, with the DOJ obtaining more than $3 billion in settlements and judgments under the Act. Of that amount, $2.6 billion came from the health care industry, and this is the 10th consecutive year that health care fraud settlements and judgments have exceeded $2 billion.
- Press ReleasePress Release
- NewsBuffalo Business First
- Press ReleasePress Release
- Press ReleasePress Release
- NewsThe New York Law JournalThe End of the Internal Investigation and the Risk of the Internal Whistleblower: Self-Disclosure in the FCPA Context
- Press ReleasePress Release
- Press ReleasePress Release
- Press ReleasePress Release
- Press ReleasePress Release
- Blog Post
A recent decision from the U,S. District Court for the District of Columbia illustrates the power of the government to block False Claims Act settlements between relators and defendants. United States ex rel. Landis v. Tailwind Sports Corp., 2015 U.S. Dist. LEXIS 46140 (D.D.C. April 9, 2015) involves former professional cyclist Floyd Landis, who brought FCA violations against Lance Armstrong and other defendants, including Armstrong’s agents and their company, called Capital Sports and Entertainment. The case was based on Landis’s allegations that defendants submitted claims for sponsorship payments to the U.S. Postal Service while knowing that the team had been using performance-enhancing drugs in violation of the sponsorship agreement.
- Press ReleasePress Release
- Blog Post
Relators alleging a retaliation claim under the False Claims Act scored a big win in the recent Sixth Circuit decision United States ex rel. Paige v. BAE Systems Technology Solutions & Services, Inc., 2014 U.S. App. LEXIS 9676 (6th Cir. May 22, 2014), which held that a False Claims Act retaliation claim was not subject to an employment agreement’s arbitration clause.
Relators in that case alleged that the defendant employer retaliated against them for cooperating with the government and filing a whistleblower case. Relators alleged that throughout their employment they complained to management about fraud, but, despite their complaints, the perpetrators of the unlawful conduct were left in place and their attempts to correct the problems were rebuffed. Ultimately, one of the relators was forced to quit due to the retaliation and the other was laid off. The district court dismissed the retaliation claim in favor of arbitration due to a clause in relators’ employment agreements.
- Blog Post
In a recent False Claims Act case from the Eighth Circuit, Rille v. PricewaterhouseCoopers LLP, 2014 U.S. App. LEXIS 6597 (8th Cir. April 10, 2014), the relators won an important victory against the government relating to their right to obtain a portion of the settlement proceeds of a claim under the act. Specifically, according to the act, if the government “intervenes” in a case brought by relators, relators are entitled to a portion “of the proceeds of the action or settlement of the claim.” 31 U.S.C. 3730(d)(1). But in Rille, the relators had to fight not only defendants, but also the government to get the recovery they were entitled to under the act. The Eighth Circuit – in no uncertain terms – sided with the relators.
- Press ReleasePress Release
- Blog Post
According to a press release from the Department of Justice, in fiscal year 2013, the government recovered $3.8 billion in settlements and judgments involving the False Claims Act. This is the second-largest annual recovery in history and brings total recoveries under the False Claims Act since January 2009 (when the act was significantly amended) to $17 billion. Additionally, the number of qui tam (or whistleblower) cases increased to 752 in 2013, which was 100 more than in fiscal year 2012. Recoveries in qui tam cases this year totaled $2.9 billion, with whistleblowers recovering $345 million.
- Blog PostHow Risperdal Whistleblowers Made Millions From J&J
In the article “How Risperdal Whistle-Blowers Made Millions From J&J,” Bloomberg News profiles a few of the whistleblowers involved in the government’s investigation of claims that pharmaceutical giant Johnson & Johnson illegally marketed the drug Risperdal for off-label uses. In November, the U.S. Department of Justice announced that Johnson & Johnson settled the investigation for $2 billion, a portion of which went to the whistleblowers profiled. Dan Oliverio, who contributes to this blog and is quoted in the Bloomberg article, leads a team of Hodgson Russ attorneys that represents two of those whistleblowers.
Reetuparna (Reena) Dutta is a senior associate in the Business Litigation Practice at Hodgson Russ LLP. You can reach her at rdutta@hodgsonruss.com.
- News
- Blog Post
Relators who have claims based on frauds that extend farther than the False Claims Act’s statute of limitations are in for good news—a recent decision regarding the Wartime Suspension of Limitations Act may mean that claims that would have been time-barred under the False Claims Act may still be actionable.
- Blog Post
A False Claims Act case can be brought by a whistleblower (relator) to recover funds on behalf of the federal government. The government then has the option to “intervene” and proceed with the action. If the government does intervene, it has the primary role in prosecuting the action, although the relator remains entitled to a percentage of any recovery. Even if the government declines to intervene initially, it can later intervene upon a showing of “good cause.”
- Blog Post
The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 included a whistleblower program allowing individuals who report original information to the SEC leading to a recovery exceeding $1 million to obtain between 10 percent and 30 percent of the recovery. It also included a prohibition on retaliation.
It has been about one year since the SEC established its Office of the Whistleblower, and according to Sean X. McKessy, the chief of that office, the SEC has received almost 3,000 securities law violation tips, or about eight tips per day.
- Blog Post
With respect to relators, in a matter of first impression before the U.S. Court of Appeals for the Ninth Circuit, the court held that knowingly false underbidding can support False Claims Act liability.
In Hooper v. Lockheed Martin, No. 11-55278 (9th Cir. Aug. 2, 2012), the relator was an engineer working for Lockheed, and he claimed that Lockheed defrauded the Air Force under a government contract by knowingly underbidding the contract. Lockheed argued that the estimates in its bid could not predicate liability because an estimate is merely an opinion or prediction, as opposed to a false statement. The relator, however, produced evidence that Lockheed employees were told to lower their bids without regard to actual cost. This evidence, according to the Ninth Circuit, raised a genuine issue as to whether Lockheed had the requisite knowledge when it submitted its bid for the contract. Thus, the court held that summary judgment for Lockheed on this claim was inappropriately granted and, in light of this decision, relators should be on the lookout for bids based on lower-than-actual costs as a potential basis for liability.
- Blog Post
While the federal False Claims Act gets the big headlines and the correspondingly big recoveries, it is important not to forget that a number of states have their own false claims acts under which relators can bring claims that also have the potential for significant monetary recoveries. States with these acts tend to fall into two categories: states with generally applicable false claims acts (like the federal law) and states that limit their acts to health care fraud.
- Blog Post
March 1, 2012, was a big day for New York State taxpayers, as both the state and federal governments announced significant settlements impacting the state. First, New York Attorney General Schneiderman announced two large settlements under the New York False Claims Act. Both settlements involve pharmaceutical companies, Dava Pharmaceuticals, Inc. and KV Pharmaceutical Company, with Dava misclassifying drugs to evade payments to Medicaid, and KV failing to advise the Centers for Medicare & Medicaid Services (CMS) that two unapproved drugs were not covered by federal and state health care programs, thereby improperly receiving reimbursement for those drugs.
- Blog Post
Parties frequently battle over whether the conduct at issue was “false” such that False Claims Act liability is appropriate. Courts have recognized two types of false claims: factually false claims and legally false claims. A factually false claim is false as to a matter of fact (for example, a claim to have provided goods that were never provided). A legally false claim involves false certifications of compliance with laws or regulations that are prerequisites to payment. Courts have further divided legally false claims into express certification and implied certification claims.
- Blog Post
There is an obvious tension between the desire to encourage employees to come forward with information necessary to report and expose fraud and the recognition that certain company information is truly private and confidential and should remain so. A recent decision from the U.S. Department of Labor Administrative Review Board further complicates the issue.
Celanese Corporation, an international publicly traded corporation, hired Matthew Vannoy to catalog and reconcile employee expense reimbursement submissions. In 2007, Vannoy filed an internal compliant about employees misusing company credit cards; around the same time, he began talking to an attorney about Celanese’s business practices with respect to its employee credit card-use program. Vannoy then filed a claim with the IRS Whistleblower Rewards Program, and he provided documents to the IRS that included Celanese proprietary and confidential information. A few months later, Vannoy’s supervisor began conducting an investigation into his email communications with employee cardholders and found that he sent a document containing 1,600 social security numbers of Celanese employees to a personal e-mail account. Vannoy was suspended without pay and ultimately terminated.
- Blog Post
False Claims Act liability has been based on defendants falsely certifying their compliance with laws and regulations. But in deciding which laws and regulations can be used as a basis of this type of liability, such that defendants deserve the huge fines and penalties of the False Claims Act, courts often have to make subjective decisions about what laws and regulations are “important” enough for this type of liability.
To take a recent example, in United States ex rel. Wilkins v. United Health Group, Inc., the U.S. Court of Appeals for the Third Circuit had to decide which laws and regulations among the hundreds of thousands imposed on Medicare participants were sufficiently seriously to merit False Claims Act liability through their violation.
- Blog Post
Federal employees may find themselves with greater whistleblower protection, if a new bill passes through Congress. The Whistleblower Protection Enhancement Act of 2011, introduced by a bipartisan group of senators, is aimed at strengthening protection for federal employees who disclose fraud and misconduct. The legislation would protect employees who blow the whistle on “gross waste or mismanagement, fraud, abuse, or illegal activity,” as well as those who disclose censorship of scientific or technical information. It will not protect disclosures of disagreements over policy.
- Blog Post
The Department of Justice (DOJ) has released its False Claims Act statistics for fiscal year 2010. According to this press release, the DOJ recovered $3 billion this year in False Claims Act recoveries, 83 percent, or $2.5 billion, of which involved health care fraud. The Obama Administration has made no secret of its focus on health care fraud, and health care companies have been in the news recently for getting caught up in false claims liability.
While the government made out pretty well this year, whistleblowers didn’t do too badly either, recovering $385 million. And one relator in particular has been in the news for her whistleblowing against one of the largest drug manufacturing companies in the world, GlaxoSmithKline, for one of the scariest health care frauds ever perpetrated.
- Blog Post
Commentators are talking about the somewhat under-the-radar whistleblower provisions in the Dodd-Frank Wall Street Reform and Consumer Protection Act, recently signed into law by President Obama. This massive law is a sweeping overhaul of the financial system, and it includes a number of provisions expanding opportunities and increasing protections for whistleblowers. The National Whistleblower Center has compiled the sections of the act pertaining to whistleblowers and has posted it here.
- Blog Post
The National Law Journal recently published an article about the increase in whistleblower lawsuits that are based on a “false marking” theory of liability in the wake of the recent appellate court decision in The Forest Group Inc. v. Bon Tool Co. The “false marking” theory of liability encompasses labeling products or packaging with an expired patent or one that doesn’t cover the product’s technology. This decision is bad news for companies with patents.
- News
Civic
- United Way, Board of Directors
- Burchfield Penney Art Center, Board of Directors
Professional
- Bar Association of Erie County, Board of Directors
Highlights
- Press Release73 Hodgson Russ LLP Attorneys Named to 2024 Upstate New York Super Lawyers List, 35 Recognized as “Rising Stars”
- Press Release93 Hodgson Russ LLP Attorneys Ranked in 2025 Edition of Best Lawyers in America
- AlertThe Final New York State Budget is Approved: Here are the Major Impacts for Hospitals, Nursing Facilities, and other Health Care Providers